Treatment of temporomandibular pain with the selective serotonin reuptake inhibitor paroxetine
- PMID: 17599175
- PMCID: PMC1894839
- DOI: 10.4088/pcc.v09n0114b
Treatment of temporomandibular pain with the selective serotonin reuptake inhibitor paroxetine
Similar articles
-
The serotonin reuptake inhibitor paroxetin is superior to the noradrenaline reuptake inhibitor maprotiline in the treatment of premenstrual syndrome.Neuropsychopharmacology. 1995 Apr;12(2):167-76. doi: 10.1016/0893-133X(94)00076-C. Neuropsychopharmacology. 1995. PMID: 7779245 Clinical Trial.
-
The pharmacologic profile of paroxetine, a new selective serotonin reuptake inhibitor.J Clin Psychiatry. 1992 Feb;53 Suppl:7-12. J Clin Psychiatry. 1992. PMID: 1531829 Review.
-
Paroxetine: an overview of the efficacy and safety of a new selective serotonin reuptake inhibitor in the treatment of depression.J Clin Psychopharmacol. 1993 Dec;13(6 Suppl 2):10S-17S. J Clin Psychopharmacol. 1993. PMID: 8106649 Review.
-
Paroxetine: a new serotonin reuptake inhibitor for the treatment of depression.Conn Med. 1993 Sep;57(9):587-92. Conn Med. 1993. PMID: 8252846 Review.
-
The clinical pharmacology and use of paroxetine, a new selective serotonin reuptake inhibitor.Pharmacotherapy. 1994 Mar-Apr;14(2):127-38. Pharmacotherapy. 1994. PMID: 8197030 Review.
Cited by
-
Paroxetine increases delta opioid responsiveness in sensory neurons.eNeuro. 2022 Jul 25;9(4):ENEURO.0063-22.2022. doi: 10.1523/ENEURO.0063-22.2022. Online ahead of print. eNeuro. 2022. PMID: 35882549 Free PMC article.
-
Temporomandibular Disorders: Fundamental Questions and Answers.Turk J Orthod. 2020 Dec 1;33(4):246-252. doi: 10.5152/TurkJOrthod.2020.20031. eCollection 2020. Turk J Orthod. 2020. PMID: 33447468 Free PMC article. Review.
-
Intra-articular biomaterials-assisted delivery to treat temporomandibular joint disorders.J Tissue Eng. 2018 May 13;9:2041731418776514. doi: 10.1177/2041731418776514. eCollection 2018 Jan-Dec. J Tissue Eng. 2018. PMID: 29785258 Free PMC article.
-
[Intravenous abuse of bupropione].Nervenarzt. 2017 Nov;88(11):1320-1322. doi: 10.1007/s00115-016-0200-3. Nervenarzt. 2017. PMID: 27525981 German. No abstract available.
References
-
- Rizzatti-Barbosa CM, Nogueira MTP, and de Andrade ED. et al. Clinical evaluation of amitriptyline for the control of chronic pain caused by temporomandibular joint disorders. Cranio. 2003 21:221–225. - PubMed
-
- Mattia C, Paoletti F, and Coluzzi F. et al. New antidepressants in the treatment of neuropathic pain: a review. Minerva Anestesiol. 2002 68:105–114. - PubMed
-
- Zung WWK.. A self-rating depression scale. Arch Gen Psychiatry. 1965;12:63–70. - PubMed
-
- Fishbain D.. Evidence-based data on pain relief with antidepressants. Ann Med. 2000;32:305–316. - PubMed
-
- Pettengill CA, Reisner-Keller L.. The use of tricyclic antidepressants for the control of chronic orofacial pain. Cranio. 1997;15:53–56. - PubMed
Publication types
LinkOut - more resources
Full Text Sources